Trial Details

COMPLETED
Basic Information
Clinical ID c4518
Identifier NCT00392951
Trial Title Sirolimus for Autoimmune Disease of Blood Cells
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Autoimmune Pancytopenia|Autoimmune Lymphoproliferative Syndrome (ALPS)|Evans Syndrome|Idiopathic Thrombocytopenic Purpura|Anemia, Hemolytic, Autoimmune|Autoimmune Neutropenia|Lupus Erythematosus, Systemic|Inflammatory Bowel Disease|Rheumatoid Arthritis
Interventions DRUG: sirolimus
Participant Information
Sponsor Children's Hospital of Philadelphia
City Philadelphia
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1|PHASE2
Time Information
Start Date 2006-12
Primary Completion Date 2016-02
Completion Date 2016-02